Epizyme To Report 2015 Financial Results And Provide Business Updates On March 9, 2016
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating novel epigenetic therapeutics for cancer patients, announced today it will host a conference call on Wednesday, March 9, 2016 at 8:00 a.m. ET to report fourth quarter and full year 2015 financial results and provide business updates.